{
    "id": "61f7d4da882a024a10000033",
    "question": "Is there an association between Guillain\u2013Barr\u00e9 syndrome and covid vaccine?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the available information about Guillain-Barr\u00e9 syndrome and its association with vaccines, particularly COVID-19 vaccines.\\n\\nFirst, we need to look for any direct evidence of an association between COVID-19 vaccines and Guillain-Barr\u00e9 syndrome. Document [0] states that there have been no confirmed cases of Guillain-Barr\u00e9 syndrome associated with influenza vaccines administered since 1976, and a similar pattern may be expected with COVID-19 vaccines. However, Document [3] mentions a possible short-term increase in the risk of Guillain-Barr\u00e9 syndrome after immunization with the diphtheria conjugate vaccine, but this finding has not been confirmed.\\n\\nNext, we need to consider the potential mechanisms by which COVID-19 vaccines could trigger Guillain-Barr\u00e9 syndrome. Document [14] provides a proposed immunopathogenesis of Guillain-Barr\u00e9 syndrome associated with Campylobacter jejuni infection, which involves molecular mimicry between the lipopolysaccharides of C. jejuni and sialylated cell surface molecules on axons. While COVID-19 vaccines contain different antigens, it is possible that a similar mechanism could be involved.\\n\\nHowever, Document [24] suggests that the risk of Guillain-Barr\u00e9 syndrome following COVID-19 vaccination is likely to be low, citing an estimated risk of <1 per million.\\n\\nConsidering these points, the available evidence does not strongly support a clear association between COVID-19 vaccines and Guillain-Barr\u00e9 syndrome. However, the question remains open to further research and surveillance.\\n\\nTherefore, the answer is B. no, there is no clear association between Guillain-Barr\u00e9 syndrome and COVID-19 vaccines based on the available information.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_14755",
            "title": "InternalMed_Harrison",
            "content": "to have been associated with an increased frequency of Guillain-Barr\u00e9 syndrome, influenza vaccines administered since 1976 generally have not been. Possible exceptions were noted during the 1992\u20131993 and 1993\u20131994 influenza seasons, when there may have been an excess risk of this syndrome (slightly more than 1 case per 1 million vaccine recipients). Large-scale studies of vaccination with the 2009 pandemic H1N1 vaccine also suggested a possible increased risk of Guillain-Barr\u00e9 syndrome (1 case per 1 million vaccinees). However, the overall health risk following influenza substantially outweighs the potential risk associated with vaccination."
        },
        {
            "id": "InternalMed_Harrison_31262",
            "title": "InternalMed_Harrison",
            "content": "Nerve conduction studies are normal, OR indicate involvement of sensory nerves only Absence of identified alternative diagnosis Level 3 of diagnostic certainty Absence of limb weakness Monophasic illness pattern and interval between onset and nadir of weakness between 12 h and 28 days and subsequent clinical plateau Absence of identified alternative diagnosis Source: From JJ Sejvar et al: Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29:599, 2011. Validation study published by C Fokke et al: Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain 137:33, 2014."
        },
        {
            "id": "Pathology_Robbins_4926",
            "title": "Pathology_Robbins",
            "content": "Guillain-Barr\u00e9 syndrome is a rapidly progressive acute demyelinating disorder affecting motor axons, resulting in ascending weakness that can lead to death from failure of respiratory muscles within days of onset of symptoms. It is one of the most common life-threatening diseases of the peripheral nervous system. Guillain-Barr\u00e9 syndrome appears to be triggered by an infection or vaccination that breaks down self-tolerance, thereby leading to an autoimmune response. Associated infectious agents include Campylobacter jejuni, Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus (HIV), and, most recently Zika virus. The injury is most extensive in the nerve roots and proximal nerve segments and is associated with mononuclear cell infiltrates rich in macrophages. Both humoral and cellular immune responses are believed to play a role in the disease process. Treatments include plasmapheresis (to remove offending antibodies), intravenous immunoglobulin infusions (which suppress"
        },
        {
            "id": "InternalMed_Harrison_12173",
            "title": "InternalMed_Harrison",
            "content": "U.S. Vaccine Adverse Events Reporting System indicated that there might be a short-term increase in the risk of Guillain-Barr\u00e9 syndrome after immunization with the diphtheria conjugate vaccine; however, further investigation has not confirmed this finding. Quadrivalent conjugate vaccines with tetanus or CRM197 as carrier protein are now available in many countries. A monovalent serogroup A vaccine, manufactured in India, was licensed in 2010 and rolled out to countries in the sub-Saharan African meningitis belt. There is strong evidence that this vaccine has been highly effective in controlling epidemic meningococcal disease in the region, with some evidence of a >90% reduction in disease in vaccinated populations. However, disease caused by serogroup X and W persists."
        },
        {
            "id": "InternalMed_Harrison_14741",
            "title": "InternalMed_Harrison",
            "content": "Central nervous system (CNS) complications such as encephalitis and transverse myelitis have been associated with influenza. Encephalitis is a rare but potentially serious complication that has been reported with influenza A and B virus infections. Children <5 years of age appear to be at greatest risk. The pathogenetic mechanisms by which influenza causes CNS disease are unclear. Guillain-Barr\u00e9 syndrome has been reported following influenza infection and, uncommonly, after influenza vaccination (see \u201cProphylaxis,\u201d below). Toxic shock syndrome associated with S. aureus or group A streptococcal infection following acute influenza infection has been described (Chaps. 172 and 173)."
        },
        {
            "id": "Neurology_Adams_7292",
            "title": "Neurology_Adams",
            "content": "a slight increase in the incidence of Guillain-Barr\u00e9 disease but not of MS (Kurland et al), and more recent surveys of immunization programs, such as the one by Confavreux and colleagues (2001), have shown similar results."
        },
        {
            "id": "Neurology_Adams_7428",
            "title": "Neurology_Adams",
            "content": "The temporal association of the neurologic disorder with vaccination supports the diagnosis and the characteristic combination of encephalitic and myelitic features will help to distinguish the condition from meningitis, viral encephalitis, and poliomyelitis. Rarely, an atypical case may mimic any one of these disorders. On occasion, the disease may suggest involvement of nerve roots and peripheral nerves and resemble acute inflammatory polyneuritis (Guillain-Barr\u00e9 syndrome). In fact, the rabies vaccine produced in South America from suckling mouse brain causes this type of peripheral nerve disease more often than encephalomyelitis. Mundane inoculations such as those for influenza or hepatitis must have a very small rate of ADEM, judging from surveillance studies; Ascherio and colleagues were unable to find any increase in cases among 2 large studies of nurses who received hepatitis B vaccine. The absence of a clear connection of MS to vaccination has already been mentioned."
        },
        {
            "id": "Obstentrics_Williams_8835",
            "title": "Obstentrics_Williams",
            "content": "Reminiscent of the rubella epidemic in the 1960s, in adults Zika infection may be asymptomatic or cause mild symptoms of rash, fever, headache, arthralgia, and conjunctivitis lasting a few days. Virus is typically detectable in blood around the time of symptom onset and may persist days to months in pregnant women (Driggers, 2016; Meaney-Delman, 2016). Serum IgM antibodies typically become detectable within the first two weeks after symptom onset and remain a median of four months (Oduyebo, 2017). Rarely, Guillain-Barre syndrome may develop following infection (da Silva, 2017; Parra, 2016)."
        },
        {
            "id": "InternalMed_Harrison_15755",
            "title": "InternalMed_Harrison",
            "content": "in serum and/or CSF. Diagnosis of tick-borne viral encephalitis primarily relies on serology and detection of viral genomes by RT-PCR. There is no specific therapy for infection. However, effective alum-adjuvanted, formalin-inactivated virus vaccines are produced in Austria, Germany, and Russia in chicken embryo cells (FSME-Immun\u00ae and Encepur\u00ae). Two doses of the Austrian vaccine separated by an interval of 1\u20133 months appear to be effective in the field, and antibody responses are similar when vaccine is given on days 0 and 14. Because rare cases of postvaccination Guillain-Barr\u00e9 syndrome have been reported, vaccination should be reserved for persons likely to experience rural exposure in an endemic area during the season of transmission. Cross-neutralization for the western/European and Far Eastern variants has been established, but there are no published field studies on cross-protection among formalin-inactivated vaccines. Because 0.2\u20134% of ticks in endemic areas may be infected,"
        },
        {
            "id": "InternalMed_Harrison_15672",
            "title": "InternalMed_Harrison",
            "content": "As previously mentioned, paralytic rabies may mimic Guillain-Barr\u00e9 syndrome. In these cases, fever, bladder dysfunction, a normal sensory examination, and CSF pleocytosis favor a diagnosis of rabies. Conversely, Guillain-Barr\u00e9 syndrome may occur as a complication of rabies vaccination with a neural tissue\u2013derived product (e.g., suckling mouse brain vaccine) and may be mistaken for paralytic rabies (i.e., vaccine failure). There is no established treatment for rabies. There have been many recent treatment failures with the combination of antiviral drugs, ketamine, and therapeutic (induced) coma\u2014measures that were used in a healthy survivor in whom antibodies to rabies virus were detected at presentation. Expert opinion should be sought before a course of experimental therapy is embarked upon. A palliative approach may be appropriate for some patients."
        },
        {
            "id": "Neurology_Adams_8253",
            "title": "Neurology_Adams",
            "content": "It came as somewhat of a surprise that an outbreak occurred in Micronesia and French Polynesia and subsequently in parts of South America, particularly Brazil, and in parts of Africa several years ago and that offspring of infected mothers had severe microcephaly. There is viral transmission from infected mother to child and an estimated one-third of infants are affected by microcephaly. Viral genome is found in infant brains and the brain is extremely small with reduced gyration in the few autopsy studies available (Mlakar and colleagues). An association with Guillain-Barr\u00e9 syndrome has been established in adults."
        },
        {
            "id": "InternalMed_Harrison_15509",
            "title": "InternalMed_Harrison",
            "content": "Paralytic disease due to enteroviruses other than poliovirus occurs sporadically and is usually less severe than poliomyelitis. Most cases are due to enterovirus 70 or 71 or to coxsackievirus A7 or A9. Guillain-Barr\u00e9 syndrome is also associated with enterovirus infection. While earlier studies suggested a link between enteroviruses and chronic fatigue syndrome, most recent studies have not demonstrated such an association."
        },
        {
            "id": "Neurology_Adams_4255",
            "title": "Neurology_Adams",
            "content": "In view of the identical autonomic disturbances in the Guillain-Barr\u00e9 syndrome and the high incidence of minor degrees of weakness, reflex loss, CSF protein elevation, and especially paresthesias, it is likely that pure pandysautonomia is also an immune-mediated polyneuropathy affecting the autonomic fibers within peripheral nerves, in most ways comparable to the Guillain-Barr\u00e9 syndrome. The aforementioned autopsy findings reported by Fagius and coworkers support such a relationship. In animals, autonomic paralysis has been produced by injection of extracts of sympathetic ganglia and Freund\u2019s adjuvant (Appenzeller et al), similar to the experimental immune neuritis that is considered as an animal model of the Guillain-Barr\u00e9 syndrome."
        },
        {
            "id": "InternalMed_Harrison_14754",
            "title": "InternalMed_Harrison",
            "content": "The major public health measure for prevention of influenza is vaccination. Both inactivated (killed) and live attenuated vaccines are available and are generated from isolates of influenza A and B viruses that circulated in the previous influenza seasons and are anticipated to circulate in the upcoming season. For inactivated vaccines, 50\u201380% protection against influenza is expected if the vaccine virus and the currently circulating viruses are closely related. Available inactivated vaccines have been highly purified and are associated with few reactions. Up to 5% of individuals experience low-grade fever and mild systemic symptoms 8\u201324 h after vaccination, and up to one-third develop mild redness or tenderness at the vaccination site. Although the 1976 swine influenza vaccine appears to have been associated with an increased frequency of Guillain-Barr\u00e9 syndrome, influenza vaccines administered since 1976 generally have not been. Possible exceptions were noted during the 1992\u20131993"
        },
        {
            "id": "InternalMed_Harrison_31244",
            "title": "InternalMed_Harrison",
            "content": "CjCjCjjCIL 3,4,5,10 CD4 Antigen presenting cell B cell TCR MHC II B cell Schwann cell plasmalemma Blood/nerve barrier Ganglioside (GM-1 and others) Myelin sheath Plasma cell lgG Cj Cj Cj O A FIGURE 460-1 Postulated immunopathogenesis of Guillain-Barr\u00e9 syndrome (GBS) associated with Campylobacter jejuni infection."
        },
        {
            "id": "Pediatrics_Nelson_3843",
            "title": "Pediatrics_Nelson",
            "content": "There are many peripheral nerve diseases in childhood, but the most classic presentations are: Guillain-Barr\u00e9 syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), hereditary motor sensory neuropathy (HMSN), and tick paralysis. Peripheral neuropathies produced by diabetes mellitus, alcoholism, chronic renal failure, exposure to toxins, vasculitis, and the effects of neoplasm are common in adults but are rare in children. Guillain-Barr\u00e9 syndrome (acute inflammatory demyelinating polyradiculoneuropathy) is a postinfectious autoimmune peripheral neuropathy that can occur about 10 days after a respiratory or gastrointestinal infection (classically Mycoplasma pneumonia or Campylobacter jejuni). It occurs in people of all ages and is the most common cause of acute flaccid paralysis in children."
        },
        {
            "id": "Neurology_Adams_5720",
            "title": "Neurology_Adams",
            "content": "occurrence of Guillain-Barr\u00e9 syndrome following Lyme infection, again apparently more common in Europe, but there is no reason to believe that the illness then differs from other cases of the acute inflammatory demyelinating polyneuropathy that follows numerous other infections."
        },
        {
            "id": "Pediatrics_Nelson_3846",
            "title": "Pediatrics_Nelson",
            "content": "The cerebrospinal fluid in Guillain-Barr\u00e9 syndrome is sometimes normal early in the illness but classically shows elevated protein levels without significant pleocytosis. Magnetic resonance imaging (MRI) with gadolinium may reveal enhancement of the spinal nerve roots. Electrophysiology studies (EMG, nerve conduction velocity [NCV]) are not always required but can provide corroborative diagnostic evidence and prognostic indicators."
        },
        {
            "id": "Neurology_Adams_5976",
            "title": "Neurology_Adams",
            "content": "both the acute (Guillain-Barr\u00e9) and chronic types, in otherwise asymptomatic patients with HIV infection. Most of these patients had a mild pleocytosis in addition to an elevated CSF protein content. Typically, patients with inflammatory demyelinating neuropathy have recovered\u2014either spontaneously or in response to plasma exchange\u2014suggesting an immunopathogenesis similar to that of the Guillain-Barr\u00e9 syndrome. Cornblath and associates suggest that all patients with inflammatory demyelinating polyneuropathies should now be tested for the presence of HIV infection. A ganglioneuronitis is also known to occur. Facial palsy is being reported with increasing frequency as a feature of HIV; its relationship to the generalized polyneuritis of AIDS is uncertain."
        },
        {
            "id": "Neurology_Adams_10420",
            "title": "Neurology_Adams",
            "content": "A proportion of axonal cases, perhaps up to one-fifth, are associated with circulating antibodies to the GM1 ganglioside of peripheral nerve, and some of these reflect recently preceding infection with C. jejuni. The acronyms AMAN (acute motor) and AMSAN (acute motor-sensory axonal neuropathy) are equivalents to axonal GBS. Another variant of this illness, of which we have seen several instances, has been an acute multifocal neuropathy with electrophysiologic motor conduction block that leaves the reflexes unaltered and has high titers of anti-GM1 antibody (Capasso et al). Most experience with the generalized axonal form of GBS indicates that recovery is prolonged and incomplete. Variants of Guillain-Barr\u00e9 Syndrome (Table 43-3)"
        },
        {
            "id": "Neurology_Adams_2116",
            "title": "Neurology_Adams",
            "content": "When a total or nearly complete loss of eye movements of both eyes evolves within a day or days, it raises a limited number of diagnostic possibilities. Keane, who analyzed 60 such cases, found the responsible lesion to lie within the brainstem in 18 (usually infarction and less often Wernicke disease), in the cranial nerves in 26 (Guillain-Barr\u00e9 syndrome or tuberculous meningitis), within the cavernous sinus in 8 (tumors or infection), and at the myoneural junction in 8 (myasthenia gravis and botulism). Our experience has tended toward the Miller Fisher variant of Guillain-Barr\u00e9 syndrome, as did Keane\u2019s later series (2007), and myasthenia. The ophthalmoplegic form of Guillain-Barr\u00e9 syndrome is very frequently associated with circulating antibodies to GQ1b ganglioside (see Chap. 44). There may be an accompanying paralysis of the dilator and constrictor of the pupil (\u201cinternal ophthalmoplegia\u201d) that is not seen in myasthenia."
        },
        {
            "id": "InternalMed_Harrison_9813",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: DT, diphtheria toxoid; DTaP, diphtheria, tetanus, and pertussis; GBS, Guillain-Barr\u00e9 syndrome; HPV, human papillomavirus; MCV4, quadrivalent meningococcal conjugate vaccine; MMR, measles, mumps, and rubella; Td, tetanus and diphtheria toxoids; Tdap, tetanus and diphtheria toxoids and acellular pertussis; TT, tetanus toxoid."
        },
        {
            "id": "InternalMed_Harrison_14375",
            "title": "InternalMed_Harrison",
            "content": "paralysis of the lower extremities or Guillain-Barr\u00e9 syndrome, follows HSV infection. Similarly, peripheral nervous system involvement (Bell\u2019s palsy) or cranial polyneuritis may be related to reactivation of HSV-1 infection."
        },
        {
            "id": "InternalMed_Harrison_15683",
            "title": "InternalMed_Harrison",
            "content": "United States. Less expensive vaccines derived from neural tissues are still used in a diminishing number of developing countries; however, these vaccines are associated with serious neuroparalytic complications, including postinfectious encephalomyelitis and Guillain-Barr\u00e9 syndrome. The use of these vaccines should be discontinued as soon as possible, and progress has been made in this regard. Worldwide, >10 million individuals receive postexposure rabies vaccine each year. If human RIG is unavailable, purified equine RIG can be used in the same manner at a dose of 40 IU/kg. Before the administration of equine RIG, hypersensitivity should be assessed by intradermal testing with a 1:10 dilution. The incidence of anaphylactic reactions and serum sickness has been low with recent equine RIG products."
        },
        {
            "id": "InternalMed_Harrison_30681",
            "title": "InternalMed_Harrison",
            "content": "Guillain-Barr\u00e9 Syndrome (Chap. 460) BP fluctuations and arrhythmias from autonomic instability can be severe. It is estimated that between 2 and 10% of patients with severe Guillain-Barr\u00e9 syndrome suffer fatal cardiovascular collapse. GI autonomic involvement, sphincter disturbances, abnormal sweating, and pupillary dysfunction can also occur. Demyelination has been described in the vagus and glossopharyngeal nerves, the sympathetic chain, and the white rami communicantes. Interestingly, the degree of autonomic involvement appears to be independent of the severity of motor or sensory neuropathy. Acute autonomic and sensory neuropathy is a variant that spares the motor system and presents with neurogenic OH and varying degrees of sensory loss. It is treated similarly to Guillain-Barr\u00e9 syndrome, but prognosis is less favorable, with persistent severe sensory deficits and variable degrees of OH in many patients."
        },
        {
            "id": "InternalMed_Harrison_31238",
            "title": "InternalMed_Harrison",
            "content": "of GBS per million persons vaccinated, and the more recent seasonal influenza vaccines appear to confer a GBS risk of <1 per million. Epidemiologic studies looking at H1N1 vaccination demonstrated at most only a slight increased risk of GBS. Meningococcal vaccinations (Menactra) does not appear to carry an increased risk. Older-type rabies vaccine, prepared in nervous system tissue, is implicated as a trigger of GBS in developing countries where it is still used; the mechanism is presumably immunization against neural antigens. GBS also occurs more frequently than can be attributed to chance alone in patients with lymphoma (including Hodgkin\u2019s disease), in HIV-seropositive individuals, and in patients with systemic lupus erythematosus (SLE). C. jejuni has also been implicated in summer outbreaks of AMAN among children and young adults exposed to chickens in rural China."
        },
        {
            "id": "Pediatrics_Nelson_3845",
            "title": "Pediatrics_Nelson",
            "content": "distinguish from an acute spinal cord syndrome. Preservation of bowel and bladder function, loss of arm reflexes, absence of a sensory level, and lack of spinal tenderness point toward Guillain-Barr\u00e9 syndrome. A cranial nerve variant of Guillain-Barr\u00e9 syndrome called the Miller Fisher variant manifests with ataxia, partial ophthalmoplegia, and areflexia."
        },
        {
            "id": "Pathology_Robbins_4928",
            "title": "Pathology_Robbins",
            "content": "CIDP is the most common chronic acquired inflammatory peripheral neuropathy, characterized by symmetrical mixed sensorimotor polyneuropathy that persists for 2 months or more. Both motor and sensory abnormalities are common, such as weakness, difficulty in walking, numbness, and pain or tingling sensations. Like Guillain-Barr\u00e9 syndrome, CIDP is immune mediated. But in contrast to Guillain-Barr\u00e9 syndrome, CIDP follows a chronic, relapsing-remitting, or progressive course. It occurs with increased frequency in patients with other immune disorders, such as systemic lupus erythematosus and HIV infection. The peripheral nerves show segments of demyelination and remyelination ("
        },
        {
            "id": "Neurology_Adams_6010",
            "title": "Neurology_Adams",
            "content": "Paralytic poliomyelitis Weakness becomes manifest while the fever is at its height, or, just as frequently, as the temperature falls and the general clinical picture seems to be improving. Muscle weakness may develop rapidly, attaining its maximum severity in 48 h or even less; or it may develop more slowly or in stuttering fashion over a week, rarely even longer. As a general rule, there is no progression of weakness after the temperature has been normal for 48 h. The distribution of spinal paralysis is quite variable; rarely there may be an acute symmetrical paralysis of the muscles of the trunk and limbs as occurs in the Guillain-Barr\u00e9 syndrome. Excessive physical activity and local injections during the period of asymptomatic infection were thought to favor the development of paralysis of the exercised or injected limbs."
        },
        {
            "id": "Neurology_Adams_2206",
            "title": "Neurology_Adams",
            "content": "The tonic pupil usually appears during the third or fourth decade of life and is much more common in women than in men; it may be associated with absence of knee or ankle jerks (Holmes-Adie syndrome) and hence be mistaken for tabes dorsalis. From all available data, it represents a special form of mild inherited polyneuropathy. There can be a familial tendency to the syndrome. We have observed it as an accompaniment of a diffuse ganglionopathy associated with Sj\u00f6gren disease, other autoimmune or paraneoplastic illnesses, and following recovery from the Guillain-Barr\u00e9 syndrome."
        },
        {
            "id": "InternalMed_Harrison_9807",
            "title": "InternalMed_Harrison",
            "content": "GBS within 6 weeks after a previous dose of TT-containing vaccine Progressive or unstable neurologic disorder, uncontrolled seizures, or progressive encephalopathy. Defer vaccination until a treatment regimen has been established and the condition has stabilized. History of arthus-type hypersensitivity reactions after a previous dose of TTor DT-containing vaccines (including MCV4). Defer vaccina tion until at least 10 years have elapsed since the last dose. HPV Contraindication History of immediate hypersensitivity to yeast (for Gardasil) Pregnancy. If a woman is found to be pregnant after initiation of the vaccination series, the remainder of the 3-dose regimen should be delayed until after completion of the pregnancy. If a vaccine dose has been administered during pregnancy, no intervention is needed. Exposure to Gardasil during pregnancy should be reported to Merck (800-986-8999); exposure to Cervarix during pregnancy should be reported to GlaxoSmithKline (888-452-9622)."
        },
        {
            "id": "InternalMed_Harrison_12789",
            "title": "InternalMed_Harrison",
            "content": "of this complication, it is now estimated that Campylobacter infections, because of their high incidence, may trigger 20\u201340% of all cases of Guillain-Barr\u00e9 syndrome. The presence of sialylated lipopolysaccharides on C. jejuni strains is a form of molecular mimicry that promotes autoimmune recognition of sialylated cell surface molecules on axons. Asymptomatic Campylobacter infection also may trigger Guillain-Barr\u00e9 syndrome. Immunoproliferative small-intestinal disease (alpha chain disease), a form of lymphoma that originates in small-intestinal mucosa-associated lymphoid tissue, has been associated with C. jejuni; antimicrobial therapy has led to marked clinical improvement."
        }
    ],
    "scores": [
        0.03896222955628897,
        0.03830235597469524,
        0.028583381738721544,
        0.02723960821786909,
        0.026002096566612697,
        0.02596180249789317,
        0.02587360852183412,
        0.02585927736203241,
        0.025144804690259235,
        0.024809781612689704,
        0.024247754445774247,
        0.02417961195333458,
        0.023259082545054415,
        0.023199543826342674,
        0.022075659532105524,
        0.02185634419651595,
        0.021817345295606166,
        0.02146807440925088,
        0.02146578542599082,
        0.0210727969348659,
        0.018354803401532373,
        0.017857142857142856,
        0.01775158743849446,
        0.017523722069176614,
        0.0172823023290313,
        0.017073525138041265,
        0.017046278833599306,
        0.01676094699350513,
        0.01647457627118644,
        0.016443850267379677,
        0.01628707627118644,
        0.016139486647653616
    ]
}